Expanded Access for Bulevirtide

Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients

NCT06051045 ·Status: RECRUITING

Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD)

NCT06122285 ·Status: RECRUITING

HEllenic Multicenter ReAl-life CLInical Study for Bulevirtide Therapy in Chronic Hepatitis D: HERACLIS-BLV

NCT05928000 ·Status: UNKNOWN

Efficacy and Safety of Bulevirtide (BLV) Therapy in HDV Chronic Hepatitis (CHD) in Italy

NCT05962307 ·Status: COMPLETED

Entecavir for Chronic Hepatitis B

NCT01323452 ·Status: COMPLETED

A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials

NCT01337479 ·Status: COMPLETED

Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials

NCT01438424 ·Status: COMPLETED ·Phase: PHASE2

An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options

NCT00042393 ·Status: APPROVED_FOR_MARKETING

Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection

NCT06603311 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

NCT07096193 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program

NCT00096811 ·Status: NO_LONGER_AVAILABLE

A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

NCT07200908 ·Status: RECRUITING ·Phase: PHASE3

Incidence of Viral Hepatitis D Relapses Upon Discontinuation of Bulevirtide in Patients With Chronic Hepatitis D and Negative HDV RNA

NCT06121427 ·Status: COMPLETED

To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)

NCT00537537 ·Status: COMPLETED ·Phase: PHASE4

Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders

NCT00704106 ·Status: COMPLETED

A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen

NCT00035789 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B

NCT01943799 ·Status: COMPLETED ·Phase: PHASE2

Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide Treatment

NCT06504485 ·Status: RECRUITING

A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection

NCT07142811 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Assessment of Response and Safety of Bulevirtide Treatment in Patients With Chronic Delta Virus Infection

NCT07116044 ·Status: COMPLETED

Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB)

NCT01155427 ·Status: COMPLETED

A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials

NCT02510300 ·Status: TERMINATED

Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection

NCT00096785 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks

NCT00862706 ·Status: WITHDRAWN ·Phase: PHASE4

A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB)

NCT04449029 ·Status: COMPLETED ·Phase: PHASE2